박
박재심 Directeur Exécutif
Other M
KR KR · DART (FSS)
Browse the full record of transactions filed by 박재심, Directeur Exécutif. Director active across 2 companies, notably 비보존 제약. Aggregated, 42 filings have been recorded. The latest transaction was filed on 30 April 2026 (Purchase). Regulator: DART (FSS). All data is accessible without signup.
Declarations 42 total
€1m 277,778 shares @ €5.202 0.0007% mcap 100.0% of flow
DART:20260507000560 · 30 Apr 2026
Ideal exit: 25 Jan 2027 (T+270) DART:20260415000525 · 15 Apr 2026
Ideal exit: 10 Jan 2027 (T+270) DART:20260415000508 · 15 Apr 2026
Ideal exit: 10 Jan 2027 (T+270) €314,335 180,954 shares
DART:20260409002937 · 9 Apr 2026
DART:20260406003902 · 6 Apr 2026
Ideal exit: 1 Jan 2027 (T+270) €936,437 180,954 shares @ €5.175 0.0005% mcap 100.0% of flow
DART:20260403003027 · 31 Mar 2026
Ideal exit: 26 Dec 2026 (T+270) 0
DART:20260331003925 · 31 Mar 2026
0
DART:20260323001067 · 23 Mar 2026
€6,474 6,694 shares @ €1.8022 0.0000% mcap 100.0% of flow
DART:20260312000416 · 5 Mar 2026
Ideal exit: 30 Nov 2026 (T+270) €907 938 shares @ €1.8022 0.0000% mcap 100.0% of flow
DART:20260312000131 · 5 Mar 2026
Ideal exit: 30 Nov 2026 (T+270) €434 452 shares @ €1.8022 0.0000% mcap 100.0% of flow
DART:20260312000032 · 5 Mar 2026
Ideal exit: 30 Nov 2026 (T+270) €2,332 3,531 shares @ €1.8022 0.0000% mcap 100.0% of flow
DART:20260312001284 · 5 Mar 2026
Ideal exit: 30 Nov 2026 (T+270) €29,241 30,232 shares @ €1.8022 0.0000% mcap 100.0% of flow
DART:20260312000316 · 5 Mar 2026
Ideal exit: 30 Nov 2026 (T+270) €5,141 2,218 shares
DART:20260312001007 · 12 Mar 2026
Ideal exit: 7 Dec 2026 (T+270) €962,250 1,067,850 shares @ €1.8022 0.0005% mcap 100.0% of flow
DART:20260312000892 · 5 Mar 2026
Ideal exit: 30 Nov 2026 (T+270) €1,371 1,419 shares @ €1.8022 0.0000% mcap 100.0% of flow
DART:20260311003307 · 5 Mar 2026
Ideal exit: 30 Nov 2026 (T+270) €4,390 4,540 shares @ €1.8022 0.0000% mcap 100.0% of flow
DART:20260311003296 · 5 Mar 2026
Ideal exit: 30 Nov 2026 (T+270) €19,244 19,897 shares @ €1.8022 0.0000% mcap 100.0% of flow
DART:20260311003174 · 5 Mar 2026
Ideal exit: 30 Nov 2026 (T+270) 36,085 shares
DART:20211222000507 · 22 Dec 2021
Ideal exit: 18 Sept 2022 (T+270) 36,085 shares
DART:20211109000056 · 9 Nov 2021
Ideal exit: 6 Aug 2022 (T+270) DART:20211025000228 · 25 Oct 2021
36,085 shares
DART:20211015000327 · 15 Oct 2021
Ideal exit: 12 Jul 2022 (T+270) DART:20211012000361 · 12 Oct 2021
36,085 shares
DART:20210910000432 · 10 Sept 2021
Ideal exit: 7 Jun 2022 (T+270) DART:20210826000295 · 26 Aug 2021
25 of 42 declarations
Load more (17 remaining) About 박재심 Park Jae-sim is an Executive Director at Bivision Pharmaceuticals. In this role, he oversees operations and participates in implementing the company’s strategy. His experience in the pharmaceutical sector enables him to guide the company towards sustainable growth and enhance the services offered to clients.